Skip to Content

View Additional Section Content

S1801 A Phase II Randomized Study of Adjuvant Versus NeoAdjuvant MK-3475 (Pembrolizumab) for Clinically Detectable Stage III-IV High-Risk Melanoma

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/NCT03698019?term=s1801&rank=1

Clinical Trial Categories

  • Melanoma
Contact
Carolann Twelves, RN at 215-481-4149

Location

  • Asplundh Cancer Pavilion
    3941 Commerce Ave.
    Willow Grove, PA 19090

Find a Physician
Search Our Directory

215-481-MEDI
215-481-6334

Schedule a
Test

215-481-EXAM
215-481-3926